REMAC Policy Statement Handbook 

REGIONAL UPDATE- 4/2017

Policy No. 96-01 RE: REMAC POLICY ELIMINATED 4/3/17

Policy No. 96-03 RE: Communication Policy REVISED 4/3/17

Policy No. 97-02 RE: Non-Transporting Emergency Vehicles REVISED 4/3/17 

Policy No. 97-04 RE: Service Medical Directors REVISED 4/3/17

Policy No. 98-03 RE: Dispatch

Policy No. 01-01 RE: Blood Draws in the Field POLICY ELIMINATED 4/3/17 

Policy No. 02-01 RE: Interfacility Transports of Patients with “Non-Protocol Drugs” REVISED 4/3/17

Policy No. 03-07 RE: CME Evaluator Status

Policy No. 04-06 RE: EMS ALS Agency Down Grades- REVISED 2/18/2004  Supersedes Policy No. 01-04

Policy No. 04-07 RE: Regional CQI Study-  POLICY ELIMINATED 4/3/17 SUPERSEDED BY 17-10

Policy No. 04-08 RE: Nitrates and Erectile Disfunction Medications  POLICY ELIMINATATED 6/2/14

Policy No. 04-10 RE: Weapons of Mass DestructionREVISED 4/3/17

Policy No. 04-12 RE: Medical Control REVISED 4/3/17

Policy No. 06-01 RE: 12 Lead EKG Acquisitions POLICY ELIMINATED 6/2/14

Policy No. 07-01 RE: Use of Hemostatic Gauze POLICY ELIMINATED 6/2/14

Policy No. 07-02 RE: Mast Trousers Supersedes Policy No. 00-05

Policy No. 07-04 RE: 2007 ALS Protocol Book Corrections POLICY ELIMINATED 6/2/14

Policy No. 07-05 RE: New Protocols- Supersedes Policies 01-05, 00-02, 98-01, 99-08, 03-01, 04-05 REVISED 4/3/17

Policy No. 07-06 RE: Pulse Oximetry  POLICY ELIMINATED 6/2/14

Policy No. 07-07 RE: Additional Equipment, Skills, and Drugs- Supersedes 96-02

Policy No. 08-01 RE: Nitronox Requirements 

Policy No. 08-02 RE: Quality Improvement 

Policy No. 08-03 RE: Blood and Blood Products POLICY ELIMINATED 4/3/17

Policy No. 08-05 RE: BLS Blood Glucometry POLICY ELIMINATED 4/3/17 SUPERSEDED BY 17-06

Policy No. 08-06 RE: Automatic ALS Dispatch

Policy No. 09-01 RE: Blood Glucometer- POLICY ELIMINATED 6/2/14

Policy No. 10-01 RE: External Jugular Access POLICY ELIMINATED 6/2/14

Policy No. 10-02 RE Dopamine Administration POLICY ELIMINATED 6/2/14

Policy No. 10-04 RE: Standing Orders for BLS Assisted Medication POLICY ELIMINATED 6/2/14

Policy No. 10-05 RE: Zofran POLICY ELIMINATED 6/2/14

Policy No. 10-06 RE: Guidance for Death in the Field REVISED 4/3/17

Policy No. 11-01 RE: Refusing Medical Care REVISED 4/3/17

Policy No. 11-02 RE: Medical Control/Destination Original- 12/2003, Revised- 2/18/04 & 07/11 Supersedes- 99-06, 97-01, 03-05, 04-03 REVISED 4/3/17

Policy No. 11-03 RE: Responsiblity for ALS Patient Care Supersedes- 99-03 REVISED 4/3/17

Policy No. 11-04 RE: BLS Aspirin Administration POLICY ELIMINATED 6/2/14

Policy No. 11-05 RE: 2010 AHA Guidelines POLICY ELIMINATED 6/2/14

Policy No. 11-06 RE: Albuterol by Basics POLICY ELIMINATED 4/3/17SUPERSEDED BY 17-06

Policy No. 12-01 RE: ALS Inspections REVISED 4/3/17

Policy No. 15-01 RE: Intranasal Naloxone Dosage  POLICY ELIMINATED 4/3/17 SUPERSEDED BY 17-06

Policy No. 17-01 RE: Approved Alternate Airways

Policy No. 17-02 RE: Refusal of Care

Policy No. 17-03 RE: Radio Failure 

Policy No. 17-04 RE: Physician on Scene

Policy No. 17-05 RE: Air Medical

Policy No. 17-06 RE: BLS Narcan, Albuterol, Blood Glucometry, and 12 Lead ECG AcquisitionPolicy Supersededs: 08-05, 11-06, 15-01, 16-01, 16-02

Policy No. 17-07 RE: Stroke 

Policy No. 17-08 RE: AEMT Additions to 2017 NYS Collaborative Protocols

Policy No. 17-09 RE: Nitroglycerin Paste 

Policy No. 17-10 RE: CQI Requirements 2017 Collaborative Protocols: Supersedes 04-07

Policy No. 17-11 RE: Medical Control Agreement 2017 NYS EMS Collaborative Protocols 

Policy No. 17-12 RE: RSI

Policy No. 17-13 RE: Hospital Destination